238 related articles for article (PubMed ID: 7033396)
1. Functional evidence for complement-activating immune complexes in the skin of patients with bullous pemphigoid.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Wheeler CE; Carlo JR
J Invest Dermatol; 1982 Jan; 78(1):52-7. PubMed ID: 7033396
[TBL] [Abstract][Full Text] [Related]
2. Pemphigoid antibody mediated attachment of peripheral blood leukocytes at the dermal-epidermal junction of human skin.
Gammon WR; Lewis DM; Carlo JR; Sams WM; Wheeler CE
J Invest Dermatol; 1980 Oct; 75(4):334-9. PubMed ID: 7000926
[TBL] [Abstract][Full Text] [Related]
3. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
Gammon WR; Inman AO; Wheeler CE
J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
[TBL] [Abstract][Full Text] [Related]
4. An in vitro model of immune complex-mediated basement membrane zone separation caused by pemphigoid antibodies, leukocytes, and complement.
Gammon WR; Merritt CC; Lewis DM; Sams WM; Carlo JR; Wheeler CE
J Invest Dermatol; 1982 Apr; 78(4):285-90. PubMed ID: 7040558
[TBL] [Abstract][Full Text] [Related]
5. Bullous pemphigoid: a correlative study of autoantibodies, circulating immune complexes and dermo-epidermal deposits.
Gomes MA; Dambuyant C; Thivolet J; Bussy R
Br J Dermatol; 1982 Jul; 107(1):43-51. PubMed ID: 6809029
[TBL] [Abstract][Full Text] [Related]
6. Deposition of the membrane attack complex of complement in bullous pemphigoid.
Dahl MV; Falk RJ; Carpenter R; Michael AF
J Invest Dermatol; 1984 Feb; 82(2):132-5. PubMed ID: 6363566
[TBL] [Abstract][Full Text] [Related]
7. A functional assay for complement-activating antibodies to the cutaneous basement membrane zone.
Gammon WR; Merritt CC
Ann N Y Acad Sci; 1983; 420():335-42. PubMed ID: 6372599
[No Abstract] [Full Text] [Related]
8. Comparison of IgG subclasses and complement binding activity of autoantibodies from patients with bullous pemphigoid and pemphigus.
Brooks WS; Lee YY; Abell E; Deng JS
J Clin Lab Anal; 1989; 3(5):307-11. PubMed ID: 2681622
[TBL] [Abstract][Full Text] [Related]
9. The complement fixing ability of anti-basement membrane zone IgG subclass of herpes gestationis and bullous pemphigoid.
Suzuki M; Watanabe C; Yaoita H
Acta Derm Venereol; 1989; 69(1):6-11. PubMed ID: 2563610
[TBL] [Abstract][Full Text] [Related]
10. Induction of leukocyte adherence at the basement membrane zone with subsequent activation of their metabolic pathway by pemphigoid antibodies and complement.
Iwatsuki K; Tagami H; Yamada M
Acta Derm Venereol; 1983; 63(4):290-5. PubMed ID: 6195859
[TBL] [Abstract][Full Text] [Related]
11. Bullous systemic lupus erythematosus.
Olansky AJ; Briggaman RA; Gammon WR; Kelly TF; Sams WM
J Am Acad Dermatol; 1982 Oct; 7(4):511-20. PubMed ID: 6754773
[TBL] [Abstract][Full Text] [Related]
12. Complement-activating immune deposits in systemic lupus erythematosus skin.
Gammon WR; Merritt CC; Henke DC; Robinson T; Henley N; DeAngelo L
J Invest Dermatol; 1983 Jul; 81(1):14-20. PubMed ID: 6345682
[TBL] [Abstract][Full Text] [Related]
13. The complement system in bullous pemphigoid. III. Fixation of C1q and C4 by pemphigoid antibody.
Jordon RE; Nordby JM; Milstein H
J Lab Clin Med; 1975 Nov; 86(5):733-40. PubMed ID: 1102620
[TBL] [Abstract][Full Text] [Related]
14. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
Gammon WR; Robinson T; Briggaman RA; Wheeler CE
J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
[TBL] [Abstract][Full Text] [Related]
15. The distribution of IgG subclasses in pemphigoid gestationis: PG factor is an IgG1 autoantibody.
Kelly SE; Cerio R; Bhogal BS; Black MM
J Invest Dermatol; 1989 May; 92(5):695-8. PubMed ID: 2654296
[TBL] [Abstract][Full Text] [Related]
16. Serum and blister fluid immune complexes in bullous pemphigoid: detection with C1q and monoclonal rheumatoid factor.
Jordon RE; Struve MF; Bushkell LL
Clin Exp Immunol; 1981 Jul; 45(1):29-36. PubMed ID: 7030538
[TBL] [Abstract][Full Text] [Related]
17. A comparative immunoelectron microscopic study of typical and atypical cases of pemphigoid.
Shimizu H; Hayakawa K; Nishikawa T
Br J Dermatol; 1988 Dec; 119(6):717-22. PubMed ID: 3060192
[TBL] [Abstract][Full Text] [Related]
18. Ultrastructural localization of in vitro binding sites of circulating anti-basement membrane zone antibodies in bullous pemphigoid.
Yamasaki Y; Nishikawa T
Acta Derm Venereol; 1983; 63(6):501-6. PubMed ID: 6198839
[TBL] [Abstract][Full Text] [Related]
19. Localized pemphigoid: a case report showing in situ deposition as well as presence in serum of IgG and IgA anti-basement membrane zone antibodies.
Sugihara K; Dekio S; Tohgi K; Jidoi J
J Dermatol; 1987 Feb; 14(1):73-6. PubMed ID: 3301954
[No Abstract] [Full Text] [Related]
20. Absence of specific histologic changes in guinea pig skin treated with bullous pemphigoid antibodies.
Gammon WR; Briggaman RA
J Invest Dermatol; 1988 Apr; 90(4):495-500. PubMed ID: 3280699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
